[ET Net News Agency, 9 September 2021] SINO BIOPHARM (01177) fell 2.95% to HK$6.57,
dipping below the 10-D SMA of HK$6.628.
It hits an intra-day low of HK$6.56, and an intra-day high of HK$6.77. The total shares
traded was 40.15 million, with a value of HK$266.66m. The active buy/sell ratio is 48:52,
with net selling turnover of HK$9.81m. UBS SEC accounts for greatest net responsive buying
turnover of HK$9.29m, with volume weighted average price of HK$6.646. CHINA INNOVATION
MARKET SER accounts for greatest net responsive selling turnover of HK$13.51m, with volume
weighted average price of HK$6.616. The stock has fallen a combined 4.09% over the past 3
consecutive trading days.
The Hang Seng Index now fell 580 points, or 2.21% to 25,740; the Hang Seng China
Enterprises Index now fell 256 points, or 2.72% to 9,192; the Hang Seng TECH Index now
fell 279 points, or 4.07% to 6,591; with an overall turnover of HK$122.32b.
The SSE Composite Index now rose 17 points, or 0.49% to 3,693, with an overall turnover
of RMB679.47b.
The SZSE Component Index now rose 10 points, or 0.07% to 14,698, with an overall
turnover of RMB363.31b.
Basic Information
-------------------------------------------
Nominal 6.570 % Chg -2.95%
High 6.770 Low 6.560
Shares Tr 40.15m Turnover 266.66m
10-D SMA 6.628 %H.V 31.497
20-D SMA 6.548 VWAP 6.642
50-D SMA 6.781 RSI14 46.009
-------------------------------------------
Status: Dipping below the 10-D SMA, active buy/sell ratio is 48:52, with net selling
turnover of HK$9.81m, falling a combined 4.09% over the past 3 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
SINO BIOPHARM (01177) 6.57 -2.95
SIHUAN PHARM (00460) 2.27 -1.73
TRAD CHI MED (00570) 3.73 -0.80
CMS (00867) 15.32 +4.64
CSPC PHARMA (01093) 9.67 +0.52
3SBIO (01530) 8.66 +0.35
FOSUN PHARMA (02196) 48.15 -4.46
WUXI APPTEC (02359) 164.00 -0.85
SH PHARMA (02607) 16.30 +1.24
PHARMARON (03759) 177.50 -0.34
-------------------------------------------------
(ed)